首页>
外国专利>
method for improving progression-free survival, in vitro method, kit, use of an oligonucleotide or polypeptide, and use of bevacizumab
method for improving progression-free survival, in vitro method, kit, use of an oligonucleotide or polypeptide, and use of bevacizumab
展开▼
机译:改善无进展生存期的方法,体外方法,试剂盒,寡核苷酸或多肽的使用以及贝伐单抗的使用
展开▼
页面导航
摘要
著录项
相似文献
摘要
The present invention provides methods for improving the progression-free survival of a patient suffering from gastrointestinal cancer, in particular, metastatic colorectal cancer (mCRC), by treatment with bevacizumab (Avastin ® ) in combination with a chemotherapy regimen by determining the expression level of one or more of VEGFA and HER2 relative to control levels in patients diagnosed with gastrointestinal cancer, in particular, metastatic colorectal cancer (mCRC). The present invention further provides for methods for assessing the sensitivity or responsiveness of a patient to bevacizumab (Avastin ® ) in combination with a chemotherapy regimen, by determining the expression level of one or more of VEGFA and HER2 relative to control levels in patients diagnosed with gastrointestinal cancer, in particular, metastatic colorectal cancer (mCRC).
展开▼